Apr 12 |
Zentalis Pharmaceuticals: Data In 1st Half Of 2024 Could Get The Ball Rolling
|
Apr 11 |
Zentalis Pharmaceuticals says Melissa Epperly resigns as CFO
|
Apr 2 |
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
|
Mar 1 |
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Feb 29 |
Zentalis files automatic mixed securities shelf
|
Feb 29 |
Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Intrinsic Value Is Potentially 98% Above Its Share Price
|
Feb 28 |
Wall Street Analysts Think Zentalis Pharmaceuticals, Inc. (ZNTL) Could Surge 136.44%: Read This Before Placing a Bet
|
Feb 28 |
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
|
Feb 28 |
Zentalis Pharmaceuticals Inc (ZNTL) Reports Full Year 2023 Financial Results and Provides ...
|
Feb 27 |
Zentalis Pharmaceuticals GAAP EPS of -$4.47 beats by $0.06
|